Advertisement

Journal of Neurology

, Volume 261, Issue 7, pp 1291–1299 | Cite as

Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm

  • Alessandra Fanciulli
  • Stefano Strano
  • Jean Pierre Ndayisaba
  • Georg Goebel
  • Laura Gioffrè
  • Massimiliano Rizzo
  • Carlo Colosimo
  • Carlo Caltagirone
  • Werner Poewe
  • Gregor K. Wenning
  • Francesco E. Pontieri
Original Communication

Abstract

A pathological nocturnal blood pressure (BP) profile, either non-dipping or reverse dipping, occurs in more than 50 % of subjects diagnosed with multiple system atrophy (MSA) or Parkinson’s disease (PD). This may play a negative prognostic role in α-synucleinopathies, but, being mostly asymptomatic, remains largely underdiagnosed. In this proof-of-concept study, we aimed at developing a decision-support algorithm to predict pathological nocturnal BP profiles during a standard tilt-table examination in PD and MSA. Sixteen MSA and 16 PD patients underwent standard tilt-table examination and 24-h ambulatory BP monitoring (24-h ABPM). Clinical and tilt test differences between patients with a normal and a pathological nocturnal BP profile at 24-h ABPM were assessed, and a decision-support algorithm was developed accordingly. 75 % of MSA and 31 % of PD patients showed a pathological nocturnal BP profile. This was associated with more pronounced orthostatic BP drop (p = 0.03), joint occurrence of orthostatic hypotension and supine hypertension (p = 0.046), and lack of BP overshoot in the late phase II (II_L, p = 0.002) and in the phase IV (p = 0.007) of the Valsalva manoeuvre. Combined ∆BP ≤0.5 mmHg in the II_L and ≤−7 mmHg in the IV phase of Valsalva manoeuvre correctly predicted a pathological nocturnal BP profile with 87.5 % sensitivity and 85.7 % specificity. Pathological nocturnal BP profiles are associated with evidence of cardiovascular noradrenergic failure in PD and MSA. The Valsalva manoeuvre is routinely performed during standard tilt-table examinations. We propose the naked-eye evaluation of Valsalva phase II_L and phase IV BP behaviour as time-sparing screening tool for pathological nocturnal BP profiles in PD and MSA.

Keywords

Parkinson’s disease Multiple system atrophy Nocturnal hypertension Orthostatic hypotension Valsalva manoeuvre 

Abbreviations

24-h ABPM

24-h ambulatory blood pressure monitoring

II_E

Early phase II of the Valsalva manoeuvre

II_L

Late phase II of the Valsalva manoeuvre

BP

Blood pressure

HR

Heart rate

OH

Orthostatic hypotension

PD

Parkinson’s disease

MSA

Multiple system atrophy

SH

Supine hypertension

Notes

Conflicts of interest

Alessandra Fanciulli: the author declares no conflict of interest. Stefano Strano: the author declares no conflict of interest. Jean Pierre Ndayisaba: the author declares no conflict of interest. Georg Goebel: the author declares no conflict of interest. Laura Gioffrè: the author declares no conflict of interest. Massimiliano Rizzo: the author declares no conflict of interest. Carlo Colosimo: the author declares no conflict of interest. Carlo Caltagirone: the author declares no conflict of interest. Werner Poewe: has received consultancy and lecture fees from Abbott, Astra Zeneca, Teva, Novartis, GSK, Boehringer-Ingelheim, UCB, Orion Pharma, Merck Serono and Merz Pharmaceuticals in relation to clinical drug development programmes for PD. Gregor K. Wenning: the author declares no conflict of interest. Francesco E. Pontieri: the author declares no conflict of interest.

References

  1. 1.
    Barone P, Antonini A et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefPubMedGoogle Scholar
  2. 2.
    Berganzo K, Diez-Arrola B et al (2013) Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related? J Neurol 260(7):1752–1756CrossRefPubMedGoogle Scholar
  3. 3.
    Calandra-Buonaura G, Guaraldi P et al (2013) Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? Neurol Sci 34(10):1875–1878CrossRefPubMedGoogle Scholar
  4. 4.
    Chobanian AV, Bakris GL et al (2003) Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252CrossRefPubMedGoogle Scholar
  5. 5.
    Davies B, Sudera D et al (1982) Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man. J Clin Invest 69(4):779–784PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Fanciulli A, Strano S et al (2013) The potential prognostic role of cardiovascular autonomic failure in alpha-synucleinopathies. Eur J Neurol 20(2):231–235CrossRefPubMedGoogle Scholar
  7. 7.
    Freeman R, Wieling W et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21(2):69–72CrossRefPubMedGoogle Scholar
  8. 8.
    Frongillo D, Stocchi F et al (1995) Ambulatory blood pressure monitoring and cardiovascular function tests in multiple system atrophy. Fundam Clin Pharmacol 9(2):187–196CrossRefPubMedGoogle Scholar
  9. 9.
    Gilman S, Wenning GK et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Goldstein (2006) Adrenalin and the inner world. An introduction to scientific integrative medicine. The John Hopkins University Press, BaltimoreGoogle Scholar
  11. 11.
    Hughes AJ, Ben-Shlomo Y et al (2001) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. 1992. Neurology 57(10 Suppl 3):S34–S38PubMedGoogle Scholar
  12. 12.
    Jain S, Goldstein DS (2012) Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 46(3):572–580PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Jordan J, Shannon JR et al (1999) Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 10(1):35–42PubMedGoogle Scholar
  14. 14.
    Kim JS, Oh YS et al (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Kollensperger M, Geser F et al (2010) Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 25(15):2604–2612CrossRefPubMedGoogle Scholar
  16. 16.
    Lawrence GP, Home PD et al (1992) Repeatability of measurements and sources of variability in tests of cardiovascular autonomic function. Br Heart J 68(2):205–211PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Lipp A, Sandroni P et al (2009) Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol 66(6):742–750PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Low PA, Denq JC et al (1997) Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve 20(12):1561–1568CrossRefPubMedGoogle Scholar
  19. 19.
    Mazza A, Ravenni R et al (2012) Arterial hypertension, a tricky side of Parkinson’s disease: physiopathology and therapeutic features. Neurol Sci 34(5):621–627Google Scholar
  20. 20.
    Okamoto LE, Gamboa A et al (2009) Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension 53(2):363–369PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Petrovic IN, Ling H et al (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27(9):1186–1190CrossRefPubMedGoogle Scholar
  22. 22.
    Pilleri M, Facchini S et al (2013) Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol 260(1):253–259CrossRefPubMedGoogle Scholar
  23. 23.
    Pilleri M, Levedianos G et al (2013) Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy. Parkinsonism Relat Disord 20(2):217–221Google Scholar
  24. 24.
    Plaschke M, Trenkwalder P et al (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16(10):1433–1441CrossRefPubMedGoogle Scholar
  25. 25.
    Robottom BJ, Weiner WJ et al (2011) Movement disorders emergencies. Part 1: hypokinetic disorders. Arch Neurol 68(5):567–572CrossRefPubMedGoogle Scholar
  26. 26.
    Schmidt C, Berg D et al (2009) Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord 24(14):2136–2142CrossRefPubMedGoogle Scholar
  27. 27.
    Senard JM, Chamontin B et al (1992) Ambulatory blood pressure in patients with Parkinson’s disease without and with orthostatic hypotension. Clin Auton Res 2(2):99–104CrossRefPubMedGoogle Scholar
  28. 28.
    Shannon J, Jordan J et al (1997) The hypertension of autonomic failure and its treatment. Hypertension 30(5):1062–1067CrossRefPubMedGoogle Scholar
  29. 29.
    Shibao C, Lipsitz LA et al (2013) ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich) 15(3):147–153CrossRefGoogle Scholar
  30. 30.
    Staessen JA, Asmar R et al (2001) Task force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit 6(6):355–370CrossRefPubMedGoogle Scholar
  31. 31.
    Tomlinson CL, Stowe R et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRefPubMedGoogle Scholar
  32. 32.
    Vogel ER, Sandroni P et al (2005) Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology 65(10):1533–1537CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Alessandra Fanciulli
    • 1
    • 2
  • Stefano Strano
    • 3
  • Jean Pierre Ndayisaba
    • 2
  • Georg Goebel
    • 4
  • Laura Gioffrè
    • 3
  • Massimiliano Rizzo
    • 3
  • Carlo Colosimo
    • 5
  • Carlo Caltagirone
    • 6
  • Werner Poewe
    • 2
  • Gregor K. Wenning
    • 2
  • Francesco E. Pontieri
    • 1
    • 6
  1. 1.Department of Neuroscience, Mental Health and Sensory Organs“Sapienza” University of RomeRomeItaly
  2. 2.Universitätsklinik für NeurologieMedizinische Universität InnsbruckInnsbruckAustria
  3. 3.Department of Heart and Great Vessels “A. Reale”“Sapienza” University of RomeRomeItaly
  4. 4.Department of Medical Statistics, Informatics and Health EconomicsMedizinische Universität InnsbruckInnsbruckAustria
  5. 5.Department of Neurology and Psychiatry“Sapienza” University of RomeRomeItaly
  6. 6.I.R.C.C.S Santa Lucia FoundationRomeItaly

Personalised recommendations